| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-05-05 |
4 |
B |
$2.98 |
$999,999 |
I/I |
335,570 |
962,956 |
0.01 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-28 |
4 |
S |
$3.01 |
$12,516 |
I/I |
(4,158) |
756,509 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-31 |
4 |
S |
$3.01 |
$29,652 |
I/I |
(9,851) |
746,658 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-26 |
4 |
S |
$3.03 |
$22,483 |
I/I |
(7,420) |
764,667 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-27 |
4 |
S |
$3.03 |
$12,120 |
I/I |
(4,000) |
760,667 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-24 |
4 |
S |
$3.06 |
$14,153 |
I/I |
(4,625) |
775,228 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-25 |
4 |
S |
$3.07 |
$9,643 |
I/I |
(3,141) |
772,087 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-21 |
4 |
S |
$3.09 |
$62,844 |
I/I |
(20,338) |
779,853 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-07 |
4 |
B |
$3.12 |
$45,230 |
D/D |
14,515 |
3,648,294 |
2.37 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-20 |
4 |
S |
$3.14 |
$13,188 |
I/I |
(4,200) |
800,191 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-14 |
4 |
S |
$3.20 |
$9,600 |
I/I |
(3,000) |
847,815 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-19 |
4 |
S |
$3.22 |
$13,714 |
I/I |
(4,259) |
804,391 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2015-06-19 |
4 |
B |
$3.32 |
$5,527,269 |
D/D |
1,664,840 |
2,185,652 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2012-03-01 |
4 |
B |
$3.33 |
$232,101 |
D/D |
69,700 |
5,632,320 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2012-03-02 |
4 |
B |
$3.33 |
$2,653,754 |
D/D |
796,923 |
6,954,144 |
2.45 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-17 |
4 |
S |
$3.34 |
$84,646 |
I/I |
(25,343) |
822,472 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-18 |
4 |
S |
$3.35 |
$46,304 |
I/I |
(13,822) |
808,650 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-04-06 |
4 |
S |
$3.40 |
$288,575 |
D/D |
(85,000) |
3,633,779 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2020-07-01 |
4 |
B |
$3.50 |
$8,000,003 |
I/I |
2,285,715 |
25,394,517 |
0.01 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-09 |
4 |
B |
$3.60 |
$626,615 |
D/D |
151,782 |
3,506,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-11 |
4 |
B |
$3.64 |
$46,289 |
D/D |
12,700 |
3,700,261 |
2.37 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-04 |
4 |
B |
$3.66 |
$146,260 |
D/D |
40,000 |
3,571,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-05 |
4 |
B |
$3.71 |
$122,791 |
D/D |
33,100 |
3,604,772 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-12 |
4 |
B |
$3.74 |
$69,293 |
D/D |
18,518 |
3,718,779 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-10 |
4 |
B |
$3.75 |
$149,952 |
D/D |
40,000 |
3,687,561 |
2.45 |
- |
|
634 Records found
|
|
Page 14 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
